Intermediate Risk Prostate Cancer
9 clinical trials · Condition
◉ Watch Intermediate Risk Prostate Cancer
| Record | Firm | Date |
|---|---|---|
| VAccination in Early and ADvanced Prostate caNCEr (NCT03815942) | University of Oxford | 2018-12-10 |
| Spot-Scanning Based Hypofractionated Proton Therapy for Low and Intermediate Risk Prostate Cancer (NCT03740191) | EBG MedAustron GmbH | 2018-07-03 |
| PROspective Multicenter Observational Study on Elective Pelvic Nodes Irradiation. (NCT03340272) | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 2017-02-21 |
| Enzalutamide + External Beam Rt For Prostate (NCT02028988) | Dana-Farber Cancer Institute | 2014-02-01 |
| Assessment of New Radiation Oncology Technologies and Treatments (NCT01379872) | Trans Tasman Radiation Oncology Group | 2011-06-01 |
Track Intermediate Risk Prostate Cancer automatically
Every clearance here is in the API, with alerts when new ones post.